|
Following the judgment in the Omagh Bombing Trial ( R v Hoey [2007] NICC 49 (20 December 2007) ) including our extensive criticism of a technique used by the Forensic Science Service Ltd (FSS) to amplify and interpret very small amounts of DNA (known as “Low Copy Number” (LCN) DNA), a review was commissioned by the new Forensic Regulator. This review, conducted by Prof. Brian Caddy, Dr Adrian Linacre and Dr Graham Taylor was released last Friday (12 th April 2008). It concluded that the technique was “robust” and “fit for purpose”, although that purpose was never defined. We are at a loss to connect the content of the report with the conclusion. If this report is to represent the scope and the depth of the work of the new office of the Forensic Regulator then we are not optimistic for the future of the quality, and in particular the reliability, of science apparently approved by the Crown for use in British courts. The Forensic Institute and other scientists acknowledge the fact that technologies exist to amplify small amounts of DNA. On that, there is ‘robust’ science published internationally by a range of institutions in a host of reputable journals. However, it is a fact that:
The Review therefore lacks sufficient authority to allow any weight to be attached to its findings until all of the defects identified by the Review and other scientists have been rectified, and the clear disagreements among providers and scientists nationally and internationally have been resolved. Even by the most generous interpretation, there is clearly no general agreement in the scientific community about the reliability of LTDNA analyses as performed by the FSS Ltd. This basic tenet of, for example the Daubert standard regarding the acceptability of forensic science evidence in courts in the USA, means that the UK is likely to see evidence presented that would not meet the standard of other comparable technologically and legally advanced systems. In short, the Report carries less weight than even a single published scientific paper (of which there have been many on this topic) and should be accorded that insignificance until the data upon which the opinions are based are made available to all and have met general scientific approval. Until then, the description of the LTDNA technique sold by the FSS Ltd as “robust” or “fit for purpose” is a denial of the serious scientific questions which remain about the reliability and validity of the technique. Taking the review as the ‘final word’ on the technique is an error with potentially serious consequences for the reputation of British science and for the Criminal Justice System. For further comment and information; Professor Allan Jamieson or Dr Scott Bader Home Office Consultation Document “Standard setting and quality regulation in forensic science” 31 August 2006 at para 12. The National Measurement System Chemical and Biological Metrology Website, part of the Department of Universities, Innovation, and Skills http://www.nmschembio.org.uk/GenericArticle.aspx?m=108&amid=586 states: “Analytical measurements made in one location should be consistent with those elsewhere. Why Is It Important? Disagreements between companies or other organisations over analytical measurements waste time and cost money. If a supplier and purchaser reach different conclusions about a product or a service in which they are trading, both will have to bear costs in resolving their differences. The laboratories used may lose business or face legal costs if the dispute escalates. Regulations cannot be fairly enforced if the relevant analytical data show inconsistencies.” Home Office Consultation Document “Standard setting and quality regulation in forensic science” 31 August 2006 at para 23: “The core proposal is that the Regulator would be independent of any forensic science provider”.
|
||||
|